Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer
Tuo Ruan et al.
ONCOTARGETS AND THERAPY (2020)
Aspirin sensitizes osimertinib-resistant NSCLC cells in vitro and in vivo via Bim-dependent apoptosis induction
Han Rui et al.
MOLECULAR ONCOLOGY (2020)
Chemical strategies to overcome resistance against targeted anticancer therapeutics
Rudolf Pisa et al.
NATURE CHEMICAL BIOLOGY (2020)
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Ayesha Murtuza et al.
CANCER RESEARCH (2019)
Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells
Sabino Russi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells
Zihao Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Muhamad Noor Alfarizal Kamarudin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients
Zhe Yang et al.
CLINICAL CANCER RESEARCH (2018)
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy
Xingwu Jiang et al.
JCI INSIGHT (2018)
Role of a novel benzoxazine derivative in the chemosensitization of colon cancer
Rejitha Suraj et al.
APOPTOSIS (2017)
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
Rama Rathore et al.
APOPTOSIS (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine
Nan Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma
Ying Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Advanced gastric cancer: Current treatment landscape and future perspectives
Antonia Digklia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Molecular mechanisms of chemoresistance in gastric cancer
Wen-Jia Shi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine
Velthe Drinberg et al.
CANCER LETTERS (2014)
Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
C. N. Sreekanth et al.
ONCOGENE (2011)
Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression
John R. Cashman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
Mirit Argov et al.
CANCER LETTERS (2009)
A Chemoenzymatic Approach to Enantiomerically Pure Amines Using Dynamic Kinetic Resolution: Application to the Synthesis of Norsertraline
Lisa K. Thalen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2009)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism
RB Walter et al.
BLOOD (2005)
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models
D Peer et al.
CANCER RESEARCH (2004)
Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group
MJ Fisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Synthesis and chemical characterization of 2-methoxy-N10-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells
G Krishnegowda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Share Paper
